All News

Robert A. Dowling, MD examines the possible impact of prostate cancer surveillance management approaches on a urology practice’s reimbursement and income.

A receptor involved with HIV therapy also appears to be linked to prostate cancer metastases, according to recent research from Thomas Jefferson University, Philadelphia.

Long-term testosterone therapy in hypogonadal men appears to be safe and does not increase the risk of prostate cancer, according to a newly published analysis of three patient registries.

In separate actions, two pharmaceutical makers have acquired the rights to a novel testosterone agent and a patented formulation for interstitial cystitis/painful bladder syndrome.

Repeated onabotulinumtoxinA 100 U (onabotA [Botox]) injections continue to provide benefit for patients with overactive bladder syndrome and urinary incontinence and without evidence of any new safety concerns, according to results of a pre-specified interim analysis in an open-label, 3-year extension study.

In Urology Times’ ninth annual State of the Specialty survey, an astounding 87% of respondents perceived “increasing government regulations” with trepidation. Unfortunately, while nearly nine in ten urologists identify the problem, far fewer take steps to address it.

Propulsion with low-intensity ultrasound is showing promise as a safe and effective method for noninvasive repositioning of kidney stones, according to the findings of a first human feasibility study being conducted by researchers at the University of Washington, Seattle.

A review of initial surgical management for patients with urolithiasis has identified an association between urologist self-referral and an increased likelihood of undergoing computed tomography imaging and extracorporeal shock wave lithotripsy (ESWL) compared with non-self-referring physicians.

Certain sunscreen chemicals may impair men’s ability to father children in a timely manner, according to a recent National Institutes of Health study that an expert in male infertility called “interesting but very preliminary.”

In this interview, Gerald H. Jordan, MD, executive secretary of the American Board of Urology, discusses various aspects of certification, including the meaning of board eligibility, why the written exam is so difficult, the future of the oral exam, and which urologists are required to undergo maintenance of certification.

Some of the urologists interviewed had not noticed any effect from the ACA, although another said he has seen fewer younger patients.

A report analyzing more than 191,000 cases of prostate cancer has found that being overweight or obese increases men’s risk for advanced prostate cancer.

Testosterone replacement therapy reduced men’s overall risks for death, nonfatal myocardial infarction, and stroke, as well as for death alone in a study presented at the American Heart Association Scientific Sessions in Chicago.

The 529 plan allows you to remove wealth from your estate while you steadily accumulate assets to help educate children, grandchildren, nieces, nephews, and even yourself, if you're planning to go back to college.

In this article, Ray Painter, MD, and Mark Painter provide some facts about the 2015 Medicare fee schedule and share some insights on how its changes will impact your practice in the New Year.

The claim alleged negligence in injuring the right ureter with a retractor during the original operation, and also claimed that the physicians were negligent in opening the bladder when removing part of the left ureter without performing a biopsy first.

Autologous pubovaginal slings are associated with a high success rate following synthetic midurethral sling failure, according to recently published data.

Results from the U.S. validation study of a test that combines plasma levels of four prostate-specific kallikreins with clinical data demonstrated it accurately predicts high-grade prostate cancer and is superior to a validated clinical variable-based risk calculator.

Blue light cystoscopy with hexaminolevulinate HCl (HAL-BLC) should be considered for initial diagnosis of nonmuscle-invasive bladder cancer, an expert panel of urologists recently concluded.

Survivors of bladder, kidney, and two other forms of cancer who smoked 20 or more cigarettes a day prior to their cancer diagnoses have an up to fivefold higher risk of developing a second smoking-associated cancer compared to survivors of the same cancers who never smoked.

Even with the GOP more firmly entrenched on Capitol Hill, a permanent fix of the sustainable growth rate formula is still a possibility, say urologist James Ulchaker, MD, and Brad Stine of the AUA.

A personalized genetic test has been shown to predict risk of prostate cancer recurrence following radical prostatectomy or radiotherapy, according to a recent study.

Dendreon Corp., the maker of sipuleucel-T (Provenge), said it expects no impact on access to the prostate cancer immunotherapy following the company’s Chapter 11 filing last week.

This video demonstrates a wide-excision prostatectomy for patients with locally advanced, high-risk prostate cancer.

These videos depict a classic tennis racquet bladder neck reconstruction and mucosal eversion as popularized by Patrick Walsh, MD, for open prostatectomy, but used by relatively few surgeons for robotic prostatectomy.

The AUA has refuted findings from a recent study that reported a modest association between vasectomy and lethal prostate cancer.

Individuals with a history of kidney stones should increase their fluid intake to achieve at least 2 liters of urine per day to prevent recurrence, and if this fails, treatment with a thiazide diuretic, citrate, or allopurinol is recommended, according to a new clinical practice guideline from the American College of Physicians.

The Centers for Medicare & Medicaid Services has approved two new Category I CPT codes for the UroLift system, a treatment for BPH, effective Jan. 1, 2015.